Mabpharm Limited (HKG:2181)

Mabpharm Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,608	2,062	1,155	1,897	1,794	4,124
Market Cap Growth	-48.68%	78.57%	-39.13%	5.75%	-56.50%	-4.76%
Enterprise Value	1,856	2,293	1,337	2,080	1,849	3,803
Last Close Price	0.39	0.50	0.28	0.46	0.43	1.00

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	19.99	32.43	-	-	-	-
PS Ratio	1.81	2.87	4.20	19.76	28.38	40.54
PB Ratio	7.19	11.78	12.20	8.40	3.96	5.58
P/TBV Ratio	25.78	11.78	12.20	8.40	3.96	5.58
P/FCF Ratio	16.64	46.68	-	44.90	-	-
P/OCF Ratio	13.55	22.94	-	30.00	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	2.09	3.19	4.87	21.66	29.24	37.38
EV/EBITDA Ratio	16.80	34.76	-	-	-	-
EV/EBIT Ratio	44.82	429.03	-	-	-	-
EV/FCF Ratio	19.21	51.91	-	49.23	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	1.59	2.08	3.50	1.38	0.43	0.08
Debt / EBITDA Ratio	3.22	5.06	-	-	-	-
Debt / FCF Ratio	3.68	8.23	-	7.37	-	-
Net Debt / Equity Ratio	1.11	1.38	2.50	0.53	0.31	-0.06
Net Debt / EBITDA Ratio	2.38	3.67	-3.37	-0.73	-0.67	0.13
Net Debt / FCF Ratio	2.56	5.48	-7.35	2.85	-0.67	0.10
Asset Turnover	0.69	0.60	0.25	0.09	0.06	0.08
Inventory Turnover	0.52	0.59	0.37	0.12	0.20	0.39
Quick Ratio	0.49	0.50	0.62	0.69	0.47	0.53
Current Ratio	0.84	0.81	1.17	1.08	1.07	1.05
Return on Equity (ROE)	58.49%	46.41%	-87.04%	-69.09%	-42.04%	-39.33%
Return on Assets (ROA)	2.00%	0.28%	-7.29%	-12.93%	-15.56%	-18.03%
Return on Capital Employed (ROCE)	5.40%	0.80%	-17.00%	-28.10%	-31.00%	-44.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	6.14%	3.08%	-11.79%	-12.16%	-13.29%	-8.68%
FCF Yield	6.01%	2.14%	-2.79%	2.23%	-11.47%	-10.36%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 18, 2026

Data Sources Report a data error